Product correctly added to cart.

discount label
SB 612111 hydrochloride
View 3D

Biosynth logo

SB 612111 hydrochloride

CAS: 371980-98-2

Ref. 3D-WPA98098

5mg
480.00 €
10mg
683.00 €
25mg
1,148.00 €
50mg
1,836.00 €
100mg
2,938.00 €
Estimated delivery in United States, on Tuesday 10 Dec 2024

Product Information

Name:
SB 612111 hydrochloride
Description:

SB 612111 hydrochloride is a drug that has been shown to have antinociceptive properties in animal models. It is a non-selective opioid receptor antagonist and its profile is similar to the potent opioid receptor antagonists, such as naloxone. SB 612111 hydrochloride was tested for pain relief in clinical studies and it was found to be effective in reducing pain. Other research has shown that SB 612111 hydrochloride can block the development of morphine tolerance, which suggests that this drug may be useful for treating chronic pain. In addition, SB 612111 hydrochloride also blocks locomotor activity and amyloid protein aggregation in animal models. This drug may have potential as an anti-amyloid therapy for Alzheimer’s disease because it has been shown to reduce amyloid protein levels in rat brains.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
454.86 g/mol
Formula:
C24H29Cl2NO·HCl
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-WPA98098 SB 612111 hydrochloride

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".